Out-of-Network Pricing Lawsuits Test MultiPlan, Zelis Business Models

Why It Matters

The lawsuits could reshape how insurers and third‑party pricing platforms negotiate out‑of‑network rates, potentially forcing greater transparency and limiting algorithmic price‑setting. A ruling against the vendors would expose insurers to massive liability and alter the economics of out‑of‑network reimbursement.

Key Takeaways

• Zelis and insurers face antitrust claims for price‑fixing via repricing tools
• MultiPlan processes over 80% of out‑of‑network claims, alleged to suppress payments
• Plaintiffs allege $19 billion underpayments; 2024 quarter alone reached $6.4 billion
• DOJ says algorithm‑driven pricing can violate Sherman Act even without explicit collusion
• Bellwether trial set for Dec 2027, signaling multi‑billion dollar litigation ahead

Pulse Analysis

Out‑of‑network reimbursement has long been a pressure point for providers, insurers and the technology firms that mediate payment rates. Platforms like Zelis and MultiPlan offer data‑rich repricing tools that promise efficiency, but they also centralize pricing benchmarks derived from in‑network contracts. When multiple insurers feed the same algorithm, the resulting uniformity can depress payments, effectively turning a competitive market into a coordinated pricing hub. This dynamic is now under legal scrutiny, as plaintiffs argue that the tools function as a de‑facto price‑fixing mechanism rather than a neutral recommendation engine.

The antitrust dimension of the cases rests on the Sherman Act’s prohibition of concerted efforts to restrain trade. Recent Department of Justice guidance highlights that even without explicit agreements, the shared use of a common pricing algorithm can satisfy the “concerted action” requirement if competitors exchange sensitive data through an intermediary. Courts have already signaled willingness to treat the repricing outputs as "take‑it‑or‑leave‑it" offers, a characterization that could broaden liability beyond traditional contract disputes. For insurers, a finding of unlawful coordination would trigger treble damages, potentially inflating exposure to tens of billions of dollars.

Beyond the courtroom, the litigation threatens to upend the business models of pricing vendors that rely on volume and data aggregation. A shift toward greater transparency could force insurers to negotiate rates on a more granular, provider‑by‑provider basis, eroding the economies of scale that platforms like MultiPlan tout. Meanwhile, providers may gain leverage to demand fair market values, reshaping cash‑flow dynamics across the healthcare supply chain. As bellwether trials approach in 2027, the industry watches closely; the outcomes will likely dictate whether algorithmic pricing remains a cornerstone of out‑of‑network reimbursement or becomes a regulated liability.